JG
Congress trade
Rep. Josh Gottheimer (D-NJ) bought $1K-$15K of REGN stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a purchase of Regeneron Pharmaceuticals, Inc. (REGN) stock worth $1K-$15K in a STOCK Act filing on Jun 16, 2022.
The trade happened on May 5, 2022, 42 days before it was made public.
REGN has moved +26.3% since the trade date, from $639.37 to $807.67 (Oct 26, 2026 close).
- Traded
- May 5, 2022
- Disclosed
- Jun 16, 2022
- Filing delay
- 42 days
- Price since
- +26.3%
- Source
- STOCK Act disclosure
Other trades in this disclosure (18)
- BuyAMGN$1K-$15KJun 16, 2022
- SellBX$1K-$15KJun 16, 2022
- SellCHKP$1K-$15KJun 16, 2022
- SellCHKP$1K-$15KJun 16, 2022
- SellCHKP$1K-$15KJun 16, 2022
- SellCHKP$1K-$15KJun 16, 2022
- BuyCOP$1K-$15KJun 16, 2022
- SellDE$1K-$15KJun 16, 2022
- BuyFMX$1K-$15KJun 16, 2022
- BuyIBM$1K-$15KJun 16, 2022
- BuyIFNNY$1K-$15KJun 16, 2022
- SellLHCG$1K-$15KJun 16, 2022
- BuyMAR$1K-$15KJun 16, 2022
- BuyNVDA$1K-$15KJun 16, 2022
- SellSTAG$1K-$15KJun 16, 2022
- SellTGT$1K-$15KJun 16, 2022
- BuyTSLA$1K-$15KJun 16, 2022
- SellTT$1K-$15KJun 16, 2022
More REGN insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.